Market News
2 min read | Updated on May 21, 2024, 15:44 IST
SUMMARY
Krsnaa Diagnostics’ revenue from operations rose 25% to ₹166.3 crore during the quarter while earnings before interest, tax, depreciation, and amortisation (EBITDA), excluding CSR and ESOP, grew 28% to ₹44.5 crore. EBITDA margin improved 100 basis points to 27% during the quarter.
Shares of Krsna Diagnostics closed 1.8% lower
Krsnaa Diagnostics on Saturday reported a 1% year-on-year (YoY) decline in its fourth-quarter net profit at ₹18.7 crore. Shares of the company were trading nearly 2% lower on Tuesday afternoon.
Revenue from operations rose 25% to ₹166.3 crore during the quarter while earnings before interest, tax, depreciation, and amortisation (EBITDA), excluding CSR and ESOP, grew 28% to ₹44.5 crore. EBITDA margin improved 100 basis points to 27% during the quarter. However, the net profit margin declined to 11% from 14% in the same period of the previous fiscal.
For the fiscal year 2024, revenue from operations grew 27% to ₹620 crore while EBITDA, excluding CSR and ESOP, grew 18% to ₹146 crore. Net profit fell 9% to ₹56.8 crore during the year.
The company’s receivable days stood at 68 days excluding receivables from Himachal Pradesh, it said.
Pallavi Bhatevara, executive director at Krsnaa Diagnostics said the firm is well-positioned to deploy 67 CT scan machines, and 23 MRI machines, establish 162 labs and set up 3,153 collection centres, all under various contractual agreements. “These recent contract wins underscore the exceptional capabilities of our in-house teams, reflecting their proficiency in navigating the intricate bidding process, meeting all necessary requirements, and ultimately securing these contracts,” Bhatevara said.
During the quarter, the firm secured an agreement with the Maharashtra government for the installation and operation of 17 MRIs and an equal number of CT machines. The company has also expanded its presence with 359 new centres nationwide.
The board of directors has declared a final dividend of ₹2.50 per equity share.
Krsnaa Diagnostics is a differentiated diagnostic services provider, both in radiology and pathology. The firm is present in 15 states and two union territories with over 3,500 centres across the country.
Shares of the company have lost over 15% since the beginning of the year. The stock has gained about 7% in the last one year.
About The Author
Next Story